Clinical Trial Update: A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression [Phase 2]

View source ↗

Summary

Phase 2 study completed evaluating the efficacy, safety, and tolerability of oral NORA520 in adults with severe postpartum depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Depression

Drugs mentioned

• NORA520

Snippet

Sponsor: DuKang Pharmaceuticals, Inc. | Conditions: Depression, Postpartum, Postpartum Depression | Phase 2 | Status: COMPLETED